

Cover Story
Conversation with The Cancer Letter
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
In Brief


Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for April 2025
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Ross Levine named chief scientific officer of Memorial Sloan Kettering Cancer Center
- Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
- How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough - Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research
- Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
- Why both somatic and germline genomic profiling are essential for precision oncology